FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gauri Varadhachary

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Heather Carlson; Renato Lenzi; Martin N Raber; Gauri R Varadhachary
A phase II study to evaluate the efficacy and toxicity of oxaliplatin in combination with gemcitabine in carcinoma of unknown primary.
P Bhosale; V Johnson; A Shah; V Shah; Gauri R Varadhachary; W Wei; Vikas Kundra
Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases.
Matthew H G Katz; Jeffrey E Lee; Peter W T Pisters; Eric Tamm; Gauri R Varadhachary; Jean-Nicolas Vauthey; Huamin Wang; Robert Wolff; Priya Bhosale; Chusilp Charnsangavej; Christopher H Crane; Jason B Fleming; James Abbruzzese; Aparna Balachandran
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gauri Varadhachary (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Heather Carlson; Renato Lenzi; Martin N Raber; Gauri R Varadhachary
A phase II study to evaluate the efficacy and toxicity of oxaliplatin in combination with gemcitabine in carcinoma of unknown primary.
International journal of clinical oncology 2013;18(2):226-31.
2013: P Bhosale; V Johnson; A Shah; V Shah; Gauri R Varadhachary; W Wei; Vikas Kundra
Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases.
European radiology 2013;23(2):400-7.
2012: Matthew H G Katz; Jeffrey E Lee; Peter W T Pisters; Eric Tamm; Gauri R Varadhachary; Jean-Nicolas Vauthey; Huamin Wang; Robert Wolff; Priya Bhosale; Chusilp Charnsangavej; Christopher H Crane; Jason B Fleming; James Abbruzzese; Aparna Balachandran
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators.
Cancer 2012;118(23):5749-56.
2012: Michael Overman; Huamin Wang; Gauri R Varadhachary
Adjuvant chemotherapy for resected periampullary adenocarcinoma.
JAMA : the journal of the American Medical Association 2012;308(18):1855; author reply 1855-6.
2012: Daniel E Abbott; David J Bentrem; Scott B Cantor; Christopher Crane; Jason B Fleming; Ryan P Merkow; Gauri R Varadhachary; Karl Y Bilimoria
Cost-effectiveness of treatment strategies for pancreatic head adenocarcinoma and potential opportunities for improvement.
Annals of surgical oncology 2012;19(12):3659-67.
2012: Ryan M Thomas; Mark J Truty; Gauri R Varadhachary; Jean-Nicolas Vauthey; Huamin Wang; Robert A Wolff; Jeffrey E Lee; Graciela M Nogueras-Gonzalez; Peter W T Pisters; David C Rice; Jason B Fleming; Wayne L Hofstetter; Matthew H G Katz
Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2012;16(9):1696-704.
2012: Jiansheng Wang; James L Abbruzzese; Jeannelyn S Estrella; Douglas B Evans; Jason B Fleming; Henry F Gomez; Matthew H Katz; Jeffrey E Lee; Lan Peng; Peter W T Pisters; Asif Rashid; Gauri R Varadhachary; Jean-Nicolas Vauthey; Hua Wang; Huamin Wang
Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.
Cancer 2012;118(15):3801-11.
2012: Mark J Truty; Gauri R Varadhachary; Jean-Nicolas Vauthey; Robert A Wolff; James L Abbruzzese; Christopher Crane; Matthew H Katz; Jeffrey E Lee; Ryan M Thomas; Jason B Fleming
Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative exploration.
Journal of the American College of Surgeons 2012;215(1):41-51; discussion 51-2.
2012: Deyali Chatterjee; Christopher Crane; Jason B Fleming; Henry F Gomez; Matthew H Katz; Jeffrey E Lee; Peter W T Pisters; Asif Rashid; Gauri R Varadhachary; Jean-Nicolas Vauthey; Hua Wang; James L Abbruzzese; Robert A Wolff; Huamin Wang
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome.
Cancer 2012;118(12):3182-90.
2012: Scott J Nystrom; Gauri R Varadhachary; Mahul B Amin; Shawn H Becker; Hialy R Gutierrez; David W Henner; John C Hornberger; Richard J Hornberger; Michael G Walker
Clinical utility of gene-expression profiling for tumor-site origin in patients with metastatic or poorly differentiated cancer: impact on diagnosis, treatment, and survival.
Oncotarget 2012;3(6):620-8.
2012: Ching-Wei D Tzeng; Gauri R Varadhachary; Jean-Nicolas Vauthey; Robert A Wolff; Lianchun Xiao; Eddie K Abdalla; Aparna Balachandran; Christopher H Crane; Jason B Fleming; David R Fogelman; Jeffrey E Lee; Peter W T Pisters; Matthew H G Katz
Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy.
Annals of surgical oncology 2012;19(6):2045-53.
2012: Eric P Tamm; Aparna Balachandran; Pryia Bhosale; Jason B Fleming; Matthew H Katz; Jeffrey H Lee; Gauri R Varadhachary
Imaging of pancreatic adenocarcinoma: update on staging/resectability.
Radiologic clinics of North America 2012;50(3):407-28.
2012: Deyali Chatterjee; Jason B Fleming; Henry F Gomez; Matthew H Katz; Jeffrey E Lee; Peter W Pisters; Asif Rashid; Gauri R Varadhachary; Hua Wang; James L Abbruzzese; Robert A Wolff; Huamin Wang
Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy.
The American journal of surgical pathology 2012;36(4):552-9.
2012: Patrick Kelly; Sunil Krishnan; Gauri R Varadhachary; Prajnan Das; Marc E Delclos; Patricia J Eifel; Hiral P Fontanilla; Anuja Jhingran; Christopher H Crane
Role of definitive radiation therapy in carcinoma of unknown primary in the abdomen and pelvis.
International journal of radiation oncology, biology, physics 2012;82(5):2012-7.
2012: Deyali Chatterjee; Christopher H Crane; Jason B Fleming; Henry F Gomez; Alina C Iuga; Matthew H Katz; Jeffrey E Lee; Peter W Pisters; Asif Rashid; Gauri R Varadhachary; Hua Wang; Robert A Wolff; James L Abbruzzese; Huamin Wang
Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma.
The American journal of surgical pathology 2012;36(3):409-17.
2012: Qing Zhao; Hua Wang; Robert Wolf; James L Abbruzzese; Aparna Balachandran; Jason Fleming; Henry F Gomez; Yun Gong; Matthew H Katz; Jeffrey E Lee; Peter W Pisters; Asif Rashid; Gauri R Varadhachary; Huamin Wang
Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis.
Annals of diagnostic pathology 2012;16(1):29-37.
2011: Ashwani K Singal; Gauri R Varadhachary; Gottumukkala S Raju; Ramu P Raju; William A Ross; Jason B Fleming; Praveen Guturu; Sathya R Jaganmohan; Milind Javle; Yong-Fang Kuo; Jeffrey H Lee
Self-expanding metal stents for biliary drainage in patients with resectable pancreatic cancer: single-center experience with 79 cases.
Digestive diseases and sciences 2011;56(12):3678-84.
2011: Matthew H G Katz; Jeffrey E Lee; E Lin; Christopher H Crane; Douglas B Evans; Jason Fleming; Milind Javle; Gauri R Varadhachary; Robert Wolff; Peter W T Pisters
Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial.
Annals of surgical oncology 2011;18(13):3615-22.
2011: David Fogelman; Mehrdad Jafari; E Lin; Jeffrey Morris; Harold Ozer; Gauri R Varadhachary; James L Abbruzzese; Bronwyn Bennett; Susie Bullock; Patti Cunningham; Henry Xiong; Robert A Wolff
Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial.
Cancer chemotherapy and pharmacology 2011;68(6):1431-8.
2011: Gauri R Varadhachary
Preoperative therapies for resectable and borderline resectable pancreatic cancer.
Journal of gastrointestinal oncology 2011;2(3):136-42.
2011: Christopher H Crane; Prajnan Das; Jason Fleming; Waqar Haque; Bridgett D Hobbs; Milind Javle; Sunil Krishnan; Jeffrey E Lee; Howard Safran; Gregg Staerkel; Gauri R Varadhachary; James L Abbruzzese; John S Yordy; Robert A Wolff
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(22):3037-43.
2011: Basil F El-Rayes; Philip A Philip; Asfar S Azmi; Anthony F Shields; Ann Marie Ferris; Kenneth Hess; Ahmad O Kaseb; Milind M Javle; Gauri R Varadhachary; Robert A Wolff; James L Abbruzzese
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer.
Investigational new drugs 2011;29(4):694-9.
2011: Gauri R Varadhachary; Huamin Wang; Shai Rosenwald; Yael Spector; James L Abbruzzese; Ranit Aharonov; Heather R Carlson; Ayelet Chajut; Dalia Cohen; Tina B Edmonston; Siddharth Karanth; Renato Lenzi; Joanna Macinskas; Martin N Raber
Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(12):4063-70.
2010: Gauri R Varadhachary; Robert A Wolff
The war on pancreatic cancer: are we gaining ground?
Oncology (Williston Park, N.Y.) 2010;24(14):1335-6.
2010: Matthew H G Katz; Gauri R Varadhachary; Jason Fleming; Robert A Wolff; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Eddie K Abdalla; Charlotte C Sun; Huamin Wang; Christopher H Crane; Jeffrey H Lee; Eric P Tamm; James L Abbruzzese; Douglas B Evans
Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation.
Annals of surgical oncology 2010;17(7):1794-801.
2010: Christopher H Crane; Gauri R Varadhachary; Robert A Wolff; Jason Fleming
Challenges in the study of adjuvant chemoradiation after pancreaticoduodenectomy.
Annals of surgical oncology 2010;17(4):950-2.
2009: Gauri R Varadhachary; Martin N Raber
Gene expression profiling in cancers of unknown primary.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(25):e85-6; author reply e87-8.
2009: Michael J Overman; Gauri R Varadhachary; Scott Kopetz; Rosnie B Adinin; Edward Lin; Jeffrey S Morris; Cathy Eng; James L Abbruzzese; Robert A Wolff
Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(16):2598-603.
2009: Matthew H G Katz; Huamin Wang; Jason Fleming; Charlotte C Sun; Rosa F Hwang; Robert A Wolff; Gauri R Varadhachary; James L Abbruzzese; Christopher H Crane; Sunil Krishnan; Jean-Nicolas Vauthey; Eddie K Abdalla; Jeffrey E Lee; Peter W T Pisters; Douglas B Evans
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.
Annals of surgical oncology 2009;16(4):836-47.
2009: Christopher H Crane; Gauri R Varadhachary; S H Settle; Jason Fleming; Douglas B Evans; Robert A Wolff
The integration of chemoradiation in the care of patient with localized pancreatic cancer.
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2009;13(2):123-43.
2009: Gauri R Varadhachary; F Anthony Greco
Overview of patient management and future directions in unknown primary carcinoma.
Seminars in oncology 2009;36(1):75-80.
2008: Gauri R Varadhachary; James L Abbruzzese
Novel approaches to 'borderline resectable' pancreatic tumors.
Oncology (Williston Park, N.Y.) 2008;22(13):1529-30.
2008: Henry Q Xiong; Gauri R Varadhachary; Joan C Blais; Kenneth R Hess; James L Abbruzzese; Robert A Wolff
Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer.
Cancer 2008;113(8):2046-52.
2008: Michael J Overman; Scott Kopetz; Gauri R Varadhachary; Masakazu Fukushima; Keizo Kuwata; Akira Mita; Robert A Wolff; Paulo Hoff; Henry Xiong; James L Abbruzzese
Phase I clinical study of three times a day oral administration of TAS-102 in patients with solid tumors.
Cancer investigation 2008;26(8):794-9.
2008: Robert A Wolff; Gauri R Varadhachary; Douglas B Evans
Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress.
Annals of surgical oncology 2008;15(10):2773-86.
2008: Michael J Overman; Gauri R Varadhachary; Scott Kopetz; Melanie Thomas; Masakazu Fukushima; Keizo Kuwata; Akira Mita; Robert A Wolff; Paulo M Hoff; Henry Xiong; James L Abbruzzese
Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors.
Investigational new drugs 2008;26(5):445-54.
2008: Gauri R Varadhachary; Dmitri Talantov; Martin N Raber; Christina Meng; Kenneth R Hess; Tim Jatkoe; Renato Lenzi; David R Spigel; Yixin Wang; F Anthony Greco; James L Abbruzzese; John D Hainsworth
Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(27):4442-8.
2008: Douglas B Evans; Gauri R Varadhachary; Christopher H Crane; Charlotte C Sun; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Huamin Wang; Karen R Cleary; Gregg Staerkel; Chusilp Charnsangavej; Elizabeth A Lano; Linus Ho; Renato Lenzi; James L Abbruzzese; Robert A Wolff
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(21):3496-502.
2008: Gauri R Varadhachary; Robert A Wolff; Christopher H Crane; Charlotte C Sun; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Eddie K Abdalla; Huamin Wang; Gregg Staerkel; Jeffrey H Lee; William A Ross; Eric P Tamm; Pryia Bhosale; Sunil Krishnan; Prajnan Das; Linus Ho; Henry Xiong; James L Abbruzzese; Douglas B Evans
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(21):3487-95.
2008: Gauri R Varadhachary; Martin N Raber; Aurelio Matamoros; James L Abbruzzese
Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions.
The lancet oncology 2008;9(6):596-9.
2008: Matthew H G Katz; Peter W T Pisters; Douglas B Evans; Charlotte C Sun; Jeffrey E Lee; Jason Fleming; Jean-Nicolas Vauthey; Eddie K Abdalla; Christopher H Crane; Robert A Wolff; Gauri R Varadhachary; Rosa F Hwang
Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.
Journal of the American College of Surgeons 2008;206(5):833-46; discussion 846-8.
2008: Gerald S Falchook; Robert A Wolff; Gauri R Varadhachary
Clinicopathologic features and treatment strategies for patients with pancreatic adenocarcinoma and ovarian metastases.
Gynecologic oncology 2008;108(3):515-9.
2008: Sunil Krishnan; Vishal Rana; Douglas B Evans; Gauri R Varadhachary; Prajnan Das; Sumita Bhatia; Marc E Delclos; Nora Janjan; Robert A Wolff; Christopher H Crane; Peter W T Pisters
Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.
International journal of radiation oncology, biology, physics 2008;70(3):735-43.
2007: Gauri R Varadhachary
Carcinoma of unknown primary origin.
Gastrointestinal cancer research : GCR 2007;1(6):229-35.
2007: Gauri R Varadhachary
Current management of borderline-resectable pancreatic cancer.
Clinical advances in hematology & oncology : H&O 2007;5(10):765-7.
2007: Cielito C Reyes-Gibby; Wenyaw Chan; James L Abbruzzese; Henry Q Xiong; Linus Ho; Douglas B Evans; Gauri R Varadhachary; Samrat Bhat; Robert A Wolff; Christopher Crane
Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation.
Journal of pain and symptom management 2007;34(3):244-52.
2007: Christopher H Crane; Gauri R Varadhachary; Peter W T Pisters; Douglas B Evans; Robert A Wolff
Future chemoradiation strategies in pancreatic cancer.
Seminars in oncology 2007;34(4):335-46.
2007: Sunil Krishnan; Vishal Rana; Nora Janjan; Gauri R Varadhachary; James L Abbruzzese; Prajnan Das; Marc E Delclos; Morris S Gould; Douglas B Evans; Robert A Wolff; Christopher H Crane
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy.
Cancer 2007;110(1):47-55.
2007: Thomas A Aloia; Thomas E Aloia; Jeffrey E Lee; Jean-Nicolas Vauthey; Eddie K Abdalla; Robert A Wolff; Gauri R Varadhachary; James L Abbruzzese; Christopher H Crane; Douglas B Evans; Peter W T Pisters
Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy?
Journal of the American College of Surgeons 2007;204(3):347-55.
2006: Sunil Krishnan; Vishal Rana; Nora Janjan; James L Abbruzzese; Morris S Gould; Prajnan Das; Marc E Delclos; Shana Palla; Sushovan Guha; Gauri R Varadhachary; Douglas B Evans; Robert A Wolff; Christopher H Crane
Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation.
Cancer 2006;107(11):2589-96.
2006: Gauri R Varadhachary; Eric P Tamm; James L Abbruzzese; Henry Q Xiong; Christopher H Crane; Huamin Wang; Jeffrey E Lee; Peter W T Pisters; Douglas B Evans; Robert A Wolff
Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy.
Annals of surgical oncology 2006;13(8):1035-46.
2006: Teresa G Hayes; Gerald F Falchook; Gauri R Varadhachary; Dori P Smith; Lisa D Davis; Hari M Dhingra; Benjamin P Hayes; Atul Varadhachary
Phase I trial of oral talactoferrin alfa in refractory solid tumors.
Investigational new drugs 2006;24(3):233-40.
2006: Christopher H Crane; Gauri R Varadhachary; Robert A Wolff; Peter W T Pisters; Douglas B Evans
The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer.
Best practice & research. Clinical gastroenterology 2006;20(2):365-82.
2006: Kenneth R Hess; Gauri R Varadhachary; Sarah H Taylor; Wei Wei; Martin N Raber; Renato Lenzi; James L Abbruzzese
Metastatic patterns in adenocarcinoma.
Cancer 2006;106(7):1624-33.
2006: Prajnan Das; Robert A Wolff; James L Abbruzzese; Gauri R Varadhachary; Douglas B Evans; Jean-Nicolas Vauthey; Andrew Baschnagel; Marc E Delclos; Sunil Krishnan; Nora Janjan; Christopher H Crane
Concurrent capecitabine and upper abdominal radiation therapy is well tolerated.
Radiation oncology (London, England) 2006;1():41.
2005: Gauri R Varadhachary; Paulo M Hoff
Front-line therapy for advanced colorectal cancer: emphasis on chemotherapy.
Seminars in oncology 2005;32(6 Suppl 9):S40-2.
2005: Gauri R Varadhachary; Eric P Tamm; Christopher Crane; Douglas B Evans; Robert A Wolff
Borderline resectable pancreatic cancer.
Current treatment options in gastroenterology 2005;8(5):377-84.
2005: Gauri R Varadhachary; Jaffer A Ajani
Preoperative and adjuvant therapies for upper gastrointestinal cancers.
Expert review of anticancer therapy 2005;5(4):719-25.
2005: Gauri R Varadhachary; Jaffer A Ajani
Gastric cancer.
Clinical advances in hematology & oncology : H&O 2005;3(2):118-24.
2004: Gauri R Varadhachary; James L Abbruzzese; Renato Lenzi
Diagnostic strategies for unknown primary cancer.
Cancer 2004;100(9):1776-85.